News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|November 3, 2017

From Breast Cancer Patient to Breast Cancer Board Member

Author(s)Laura Yeager

Akron, Ohio's best kept secret may revolutionize breast cancer treatment.

Advertisement

As you might know from reading my blog posts here at

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
lung cancer image

Lung Carcinoid Tumors: Diagnosis, Staging and Treatment Options

BySpencer Feldman
January 31st 2026
Dr. Suneel Kamath highlighted advances in biomarker-driven therapies and emerging frontline regimens following the 2026 ASCO GI Cancers Symposium.

Key GI Cancer Advances from the 2026 ASCO Symposium

ByRyan Scott
January 30th 2026
breast cancer

Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

ByCURE staff
January 30th 2026
Image of Dr. Obeid.

Risk Assessment Remains Vital for Patients Even After Cancer Diagnosis

ByDr. Elias Obeid
January 30th 2026
Bonnie Annis

The Last Walk Down the Hall: Reflections Before Entering Cancer Survivorship

ByBonnie Annis
January 30th 2026
Advertisement
Advertisement

Trending on CURE

1

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

2

Key GI Cancer Advances from the 2026 ASCO Symposium

3

Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer

4

FDA Accepts Ivonescimab Application for EGFR Lung Cancer

5

Study Identifies Why Some Breast Cancers Resist Enhertu Treatment

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.